600380 健康元
已收盘 10-09 15:00:00
资讯
新帖
简况
健康元（600380）披露为控股子公司提供担保进展情况，10月09日股价上涨2.32%
证券之星 · 10-09 22:27
健康元（600380）披露为控股子公司提供担保进展情况，10月09日股价上涨2.32%
健康元最新公告：子公司注射用醋酸亮丙瑞林微球11.25mg获批上市
证券之星 · 09-29
健康元最新公告：子公司注射用醋酸亮丙瑞林微球11.25mg获批上市
9月28日健康元涨5.84%，国联安小盘精选混合基金重仓该股
证券之星 · 09-28
9月28日健康元涨5.84%，国联安小盘精选混合基金重仓该股
健康元涨5.84%，开源证券一个月前给出“买入”评级
证券之星 · 09-28
健康元涨5.84%，开源证券一个月前给出“买入”评级
股市必读：健康元新发布《健康元药业集团股份有限公司2026年第一次临时股东会的法律意见》
证券之星 · 09-28
股市必读：健康元新发布《健康元药业集团股份有限公司2026年第一次临时股东会的法律意见》
健康元（600380）披露2026年中期利润分配预案，9月24日股价下跌1.7%
证券之星 · 09-24
健康元（600380）披露2026年中期利润分配预案，9月24日股价下跌1.7%
股市必读：健康元（600380）9月23日董秘有最新回复
证券之星 · 09-24
股市必读：健康元（600380）9月23日董秘有最新回复
健康元：已形成“企业级部署、全产业链覆盖、真实业务应用、量化成果验证”的系统能力
证券之星 · 09-23
健康元：已形成“企业级部署、全产业链覆盖、真实业务应用、量化成果验证”的系统能力
“药二代”密集走向台前，大多拥有海外名校背景，将如何接好“转型”这一棒？
红星资本局 · 09-22
“药二代”密集走向台前，大多拥有海外名校背景，将如何接好“转型”这一棒？
健康元：关于选举公司非独立董事的公告
证券日报网 · 09-18
健康元：关于选举公司非独立董事的公告
股市必读：健康元（600380）9月8日董秘有最新回复
证券之星 · 09-09
股市必读：健康元（600380）9月8日董秘有最新回复
健康元：公司现有多款治疗哮喘的吸入制剂
证券之星 · 09-07
健康元：公司现有多款治疗哮喘的吸入制剂
健康元：公司目前暂无专门针对鼻病毒的特效抗病毒药物
证券之星 · 09-07
健康元：公司目前暂无专门针对鼻病毒的特效抗病毒药物
健康元：BD合作引进与自主研发并行
证券之星 · 09-07
健康元：BD合作引进与自主研发并行
健康元：公司当前销售费用率处于行业合理水平
证券之星 · 09-07
健康元：公司当前销售费用率处于行业合理水平
健康元：全力推进产品上量
证券之星 · 09-07
健康元：全力推进产品上量
健康元：持有ω-3鱼油中/长链脂肪乳注射液注册批件
证券之星 · 09-07
健康元：持有ω-3鱼油中/长链脂肪乳注射液注册批件
健康元：公司将结合整体产业战略、资金分配规划及各项合规要求综合研判、审慎决策各种方案
证券之星 · 09-07
健康元：公司将结合整体产业战略、资金分配规划及各项合规要求综合研判、审慎决策各种方案
子公司收购的越南IMP医药公司，是否养实验猴？健康元回应
同花顺 · 09-07
子公司收购的越南IMP医药公司，是否养实验猴？健康元回应
健康元：公司目前暂无变更公司名称或证券简称的相关计划与安排
证券之星 · 09-07
健康元：公司目前暂无变更公司名称或证券简称的相关计划与安排
加载更多
公司概况
公司名称：
健康元药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2001-06-08
主营业务：
健康元药业集团股份有限公司的主营业务是医药产品及保健品研发、生产及销售。公司的主要产品是化学制剂、生物制品、化学原料药及中间体、中药制剂、诊断试剂及设备、保健食品。
发行价格：
24.80
{"stockData":{"symbol":"600380","market":"SH","secType":"STK","nameCN":"健康元","latestPrice":10.13,"timestamp":1791529200000,"preClose":9.9,"halted":0,"volume":24047101,"delay":0,"changeRate":0.0232,"floatShares":1829000000,"shares":1829000000,"eps":0.655,"marketStatus":"已收盘","change":0.23,"latestTime":"10-09 15:00:00","open":9.87,"high":10.17,"low":9.86,"amount":242000000,"amplitude":0.0313,"askPrice":10.14,"askSize":451,"bidPrice":10.13,"bidSize":299,"shortable":0,"etf":0,"ttmEps":0.655,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791768600000},"marketStatusCode":5,"adr":0,"adjPreClose":9.9,"symbolType":"stock","openAndCloseTimeList":[[1791509400000,1791516600000],[1791522000000,1791529200000]],"highLimit":10.89,"lowLimit":8.91,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1829453386,"isCdr":false,"pbRate":1.22,"roa":"--","peRate":15.465649,"roe":"4.21%","epsLYR":0.73,"committee":-0.440767,"marketValue":18532000000,"turnoverRate":0.0131,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-10-12。","floatMarketCap":18532000000},"requestUrl":"/m/hq/s/600380","defaultTab":"news","newsList":[{"id":"2674509238","title":"健康元（600380）披露为控股子公司提供担保进展情况，10月09日股价上涨2.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674509238","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674509238?lang=zh_cn&edition=full","pubTime":"2026-10-09 22:27","pubTimestamp":1791556037,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘，健康元报收于10.13元，较前一交易日上涨2.32%，最新总市值为185.32亿元。该股当日开盘9.87元，最高10.17元，最低9.86元，成交额达2.42亿元，换手率为1.31%。近日，健康元药业集团股份有限公司发布《关于为控股子公司提供担保进展情况的公告》。截至2026年9月30日，公司对外担保余额为229,971.34万元，占最近一期经审计净资产的15.15%，无逾期担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900038484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0114","BK0188","BK0239","BK0028","600380","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671290747","title":"健康元最新公告：子公司注射用醋酸亮丙瑞林微球11.25mg获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2671290747","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671290747?lang=zh_cn&edition=full","pubTime":"2026-09-29 17:38","pubTimestamp":1790674689,"startTime":"0","endTime":"0","summary":"健康元(600380.SH)公告称，公司控股子公司丽珠集团旗下上海丽珠收到国家药监局核准签发的《药品补充申请批准通知书》，注射用醋酸亮丙瑞林微球11.25mg(3个月剂型)获批上市。该药品为《国家基本医疗保险、工伤保险和生育保险药品目录》乙类品种，适应症包括绝经前乳腺癌、前列腺癌及中枢性性早熟。截至目前，该药品累计研发投入约9405.48万元。国内仅上海丽珠持有该剂型批文(不含原研)，2025年国内长效GnRHa缓释制剂终端销售额约109亿元，其中3个月剂型占比27%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900029340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600380","BK0077","BK0046","BK0239","BK0028","BK0114","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670280667","title":"9月28日健康元涨5.84%，国联安小盘精选混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2670280667","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670280667?lang=zh_cn&edition=full","pubTime":"2026-09-28 16:36","pubTimestamp":1790584581,"startTime":"0","endTime":"0","summary":"证券之星消息，9月28日健康元涨5.84%，收盘报9.79元，换手率2.62%，成交量47.94万手，成交额4.64亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共6家，其中持有数量最多的公募基金为国联安基金的国联安小盘精选混合。国联安小盘精选混合目前规模为7.65亿元，最新净值0.989，较上一交易日下跌0.7%，近一年下跌4.99%。国联安小盘精选混合的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800021407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","600380","BK0077","BK0239","BK0046","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670806982","title":"健康元涨5.84%，开源证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2670806982","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670806982?lang=zh_cn&edition=full","pubTime":"2026-09-28 16:36","pubTimestamp":1790584571,"startTime":"0","endTime":"0","summary":"今日健康元（600380）涨5.84%，收盘报9.79元。2026年8月27日，开源证券研究员余汝意,阮帅发布了对健康元的研报《公司信息更新报告：2026上半年业绩有所承压，在研项目进展顺利》，该研报对健康元给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为69.67%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为天风证券的郑薇。健康元（600380）个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800021399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600380","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670616401","title":"股市必读：健康元新发布《健康元药业集团股份有限公司2026年第一次临时股东会的法律意见》","url":"https://stock-news.laohu8.com/highlight/detail?id=2670616401","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670616401?lang=zh_cn&edition=full","pubTime":"2026-09-28 03:14","pubTimestamp":1790536452,"startTime":"0","endTime":"0","summary":"健康元药业集团股份有限公司2026年第一次临时股东会决议公告健康元药业集团股份有限公司于2026年9月24日召开2026年第一次临时股东会，审议通过《关于2026年中期利润分配预案的议案》和《关于修订〈公司章程〉部分条款的议案》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0077","BK0188","BK0114","BK0239","600380","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669591499","title":"健康元（600380）披露2026年中期利润分配预案，9月24日股价下跌1.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669591499","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669591499?lang=zh_cn&edition=full","pubTime":"2026-09-24 22:28","pubTimestamp":1790260104,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，健康元报收于9.25元，较前一交易日下跌1.7%，最新总市值为169.22亿元。该股当日开盘9.37元，最高9.45元，最低9.23元，成交额达1.14亿元，换手率为0.67%。近日，健康元药业集团股份有限公司发布2026年第一次临时股东会决议公告，披露公司于2026年9月24日召开2026年第一次临时股东会，审议通过《关于2026年中期利润分配预案的议案》和《关于修订〈公司章程〉部分条款的议案》。中小投资者对两项议案均单独计票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400041431.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0028","BK0046","600380","BK0114","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669438766","title":"股市必读：健康元（600380）9月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2669438766","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669438766?lang=zh_cn&edition=full","pubTime":"2026-09-24 01:44","pubTimestamp":1790185455,"startTime":"0","endTime":"0","summary":"截至2026年9月23日收盘，健康元报收于9.41元，上涨0.32%，换手率0.74%，成交量13.59万手，成交额1.28亿元。董秘最新回复投资者： 本地化部署DeepSeek、OpenClaw AI智能体，搭建端到端AIDD平台：靶点识别、分子生成、ADMET预测、逆合成分析 。综合来看，健康元已经形成“企业级部署、全产业链覆盖、真实业务应用、量化成果验证”的系统能力。当日关注点交易信息汇总：9月23日主力资金净流出680.88万元，占总成交额5.33%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400002144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600380","BK0077","BK0046","BK0239","BK0028","BK0114","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669105665","title":"健康元：已形成“企业级部署、全产业链覆盖、真实业务应用、量化成果验证”的系统能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2669105665","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669105665?lang=zh_cn&edition=full","pubTime":"2026-09-23 15:33","pubTimestamp":1790148789,"startTime":"0","endTime":"0","summary":"在技术底座方面，公司已完成主流大模型的本地化、企业级部署，并进一步部署新一代AI智能体，相关应用已覆盖高层管理、研发、生产、质量、职能及销售等核心部门。综合来看，健康元已经形成“企业级部署、全产业链覆盖、真实业务应用、量化成果验证”的系统能力。未来，公司将继续深化AI技术与医药全产业链的融合，推动更多成果转化为研发效率、运营效率和长期创新能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300021510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0077","BK0114","BK0028","BK0046","BK0239","600380"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669234144","title":"“药二代”密集走向台前，大多拥有海外名校背景，将如何接好“转型”这一棒？","url":"https://stock-news.laohu8.com/highlight/detail?id=2669234144","media":"红星资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669234144?lang=zh_cn&edition=full","pubTime":"2026-09-22 20:16","pubTimestamp":1790079360,"startTime":"0","endTime":"0","summary":"红星资本局注意到，“药二代”们正密集走向台前。与“创一代”不同的是，他们大多拥有海外名校背景，进入核心管理层的方式也各不相同。今年以来，还有多位“药二代”走向台前。多家药企处于业务转型期二代接棒或面临考验值得一提的是，近期迎来“药二代”上台的上市公司，多数处于业务转型期。“药二代”走向前台，企业如何完成转型，仍有待时间验证。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-09-22/doc-inistexc1956967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0046","IE00BZ08YR35.GBP","LU1226287529.USD","BK1521","KURE","BK0114","LU1226288253.USD","600380","IE00B543WZ88.USD","688166","BK0251","BK1191","SG9999004220.SGD","LU0315179316.USD","01093","LU0880133367.SGD","BK0102","LU1226288170.HKD","LU1807302812.USD","LU1226287875.USD","LU1960683339.HKD","LU1226287792.SGD","LU0326950275.SGD","BK0077","300453","IE0008368742.USD","IE00BZ08YS42.EUR","LU2039709279.SGD","BK0239","LU0140636845.USD","BK0187","LU1152091754.HKD","BK0028","LU0067412154.USD","LU0072913022.USD","000513","IE00B031HY20.USD","IE00BZ08YT58.USD","LU1152091168.USD","LU1951186391.HKD","BK0188","LU0501845795.SGD","LU0314109678.HKD","LU1008478684.HKD","LU1328277881.USD","300298","LU1993786604.SGD","LU1813983027.USD","IE0008369823.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668492198","title":"健康元：关于选举公司非独立董事的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2668492198","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668492198?lang=zh_cn&edition=full","pubTime":"2026-09-18 21:08","pubTimestamp":1789736880,"startTime":"0","endTime":"0","summary":"证券日报网讯 9月18日，健康元发布公告称，公司于2026年9月18日召开第九届董事会第二十四次会议，审议通过《关于选举公司非独立董事的议案》，拟选举朱琳琳女士为公司第九届董事会非独立董事，任期自公司股东会审议通过之日起至第九届董事会任期届满之日止。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-18/doc-inishenv3512532.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-18/doc-inishenv3512532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["600380","BK0077","BK0114","BK0046","BK0188","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374466","title":"股市必读：健康元（600380）9月8日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374466","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666374466?lang=zh_cn&edition=full","pubTime":"2026-09-09 01:01","pubTimestamp":1788886885,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘，健康元报收于9.57元，上涨0.31%，换手率1.05%，成交量19.27万手，成交额1.84亿元。公司 AI 制药与合成生物学赛道积极布局，持续推进技术研发并取得阶段性成果。AI 药物研发方面，公司搭建医药智能研发平台，覆盖靶点挖掘、分子设计、处方筛选、临床方案设计等新药研发全链条，可有效压缩创新药早期研发周期，降低研发试错投入。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900002095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0028","BK0077","600380","BK0046","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319777","title":"健康元：公司现有多款治疗哮喘的吸入制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665319777?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:27","pubTimestamp":1788773236,"startTime":"0","endTime":"0","summary":"证券之星消息，健康元(600380)09月07日在投资者关系平台上答复投资者关心的问题。投资者提问：近期，各地强对流天气不断，造成雷暴雨极端气候，很多医院因我雷暴哮喘人满为患，强雷暴空气中的花粉和孢子到处飘散，贵公司有没有针对性药物？健康元回复：尊敬的投资者，您好，雷雨天气花粉、孢子扩散引发的雷暴哮喘，多表现为哮喘急性发作。公司现有多款治疗哮喘的吸入制剂，能够对症缓解气道痉挛，满足临床救治需求。但该类药品均为处方药，注意需在专业医师指导下合理使用。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700022263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0114","BK0028","BK0188","600380","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665831977","title":"健康元：公司目前暂无专门针对鼻病毒的特效抗病毒药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2665831977","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665831977?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:27","pubTimestamp":1788773234,"startTime":"0","endTime":"0","summary":"证券之星消息，健康元(600380)09月07日在投资者关系平台上答复投资者关心的问题。投资者提问：近期鼻病毒显著高发，健康元有没有针对性药物？健康元回复：尊敬的投资者，您好。公司目前暂无专门针对鼻病毒的特效抗病毒药物。鼻病毒感染多引发上呼吸道炎症，容易诱发咳嗽、喘息甚至哮喘急性发作。公司拥有较为完善的呼吸类对症药物，布地奈德、特布他林等吸入制剂，可有效缓解气道炎症与痉挛，改善鼻病毒感染继发的呼吸道症状。但该类药品均为处方药，注意需在专业医师指导下合理使用。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700022260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0077","BK0114","BK0046","BK0028","600380","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665197053","title":"健康元：BD合作引进与自主研发并行","url":"https://stock-news.laohu8.com/highlight/detail?id=2665197053","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665197053?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:27","pubTimestamp":1788773234,"startTime":"0","endTime":"0","summary":"证券之星消息，健康元09月07日在投资者关系平台上答复投资者关心的问题。在通过BD合作快速搭建创新管线的同时，公司也在持续推进自主研发布局，稳步夯实自研创新能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700022259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0077","BK0114","600380","BK0188","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319720","title":"健康元：公司当前销售费用率处于行业合理水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319720","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665319720?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:27","pubTimestamp":1788773233,"startTime":"0","endTime":"0","summary":"证券之星消息，健康元09月07日在投资者关系平台上答复投资者关心的问题。同时通过数字化运营、全渠道布局优化，持续提升费用投放精准度与转化效率，稳固销售费用合理可控的状态。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700022258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0114","BK0239","BK0077","BK0188","BK0046","600380"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319703","title":"健康元：全力推进产品上量","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319703","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665319703?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:27","pubTimestamp":1788773233,"startTime":"0","endTime":"0","summary":"证券之星消息，健康元09月07日在投资者关系平台上答复投资者关心的问题。当前公司首要工作是全力推进产品上量，通过常态化全国学术交流，向医院科室充分传递产品循证疗效，稳步拓展各级医院准入覆盖，同步做好患者科普宣教，提升医患对规范足疗程治疗的认知，同时优化渠道配送保障院内稳定供货，多措并举逐步提升产品市场普及率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700022257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0028","BK0046","600380","BK0114","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319773","title":"健康元：持有ω-3鱼油中/长链脂肪乳注射液注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319773","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665319773?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:27","pubTimestamp":1788773232,"startTime":"0","endTime":"0","summary":"证券之星消息，健康元(600380)09月07日在投资者关系平台上答复投资者关心的问题。投资者提问：国家要求发展海洋生物医药，AI大模型表示健康元涉足，能否披露下健康元涉足哪些海洋生物药？健康元回复：尊敬的投资者，您好，公司持有ω-3鱼油中/长链脂肪乳注射液的注册批件，该产品属于海洋来源的制剂，但是暂未形成重大销售，谢谢。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700022254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0077","BK0028","600380","BK0046","BK0114","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319708","title":"健康元：公司将结合整体产业战略、资金分配规划及各项合规要求综合研判、审慎决策各种方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319708","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665319708?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:27","pubTimestamp":1788773224,"startTime":"0","endTime":"0","summary":"证券之星消息，健康元(600380)09月07日在投资者关系平台上答复投资者关心的问题。投资者提问：公司股价已经处于及时低位估值水平，建议通过增持丽珠集团股票方式，可以同时提振丽珠集团和健康元估价，关键是提高持股比例，增厚归属母公司利润健康元回复：尊敬的投资者，您好，感谢您的宝贵建议。公司将结合整体产业战略、资金分配规划及各项合规要求综合研判、审慎决策各种方案。现阶段资金资源也需优先保障两家企业创新研发、国际化布局等长期发展投入。若后续推出相关安排，公司会严格依照信息披露相关规定，第一时间对外公告。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700022249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0046","BK0188","600380","BK0028","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665313375","title":"子公司收购的越南IMP医药公司，是否养实验猴？健康元回应","url":"https://stock-news.laohu8.com/highlight/detail?id=2665313375","media":"同花顺","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665313375?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:13","pubTimestamp":1788772380,"startTime":"0","endTime":"0","summary":"有投资者向健康元(600380.SH)提问，健康元子公司收购的越南IMP医药公司，是不是有养实验猴？9月7日，公司回答表示，越南IMP公司是越南本土上市制药企业，主营业务为化学制剂的研发、生产与 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260907/c679661641.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260907/c679661641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0239","FVNmain","BK0046","BK0114","BK0188","BK0077","600380","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319680","title":"健康元：公司目前暂无变更公司名称或证券简称的相关计划与安排","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665319680?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:12","pubTimestamp":1788772330,"startTime":"0","endTime":"0","summary":"证券之星消息，健康元(600380)09月07日在投资者关系平台上答复投资者关心的问题。投资者提问：请问上市公司，有没有打算更名，比如健康科技？健康元回复：尊敬的投资者，您好。感谢您的建议，公司目前暂无变更公司名称或证券简称的相关计划与安排。若未来涉及更名事项，公司将严格履行法定的审议程序以及交易所信息披露义务，所有相关事项请以公司正式公告为准。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700021959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0114","BK0077","161027","600380","BK0046","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791595094928,"stockEarnings":[{"period":"1week","weight":-0.003},{"period":"1month","weight":0.0731},{"period":"3month","weight":0.01},{"period":"6month","weight":-0.0707},{"period":"1year","weight":-0.1744},{"period":"ytd","weight":-0.103}],"compareEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.0349},{"period":"3month","weight":-0.0456},{"period":"6month","weight":-0.0433},{"period":"1year","weight":-0.0305},{"period":"ytd","weight":-0.0391}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"健康元药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"74898人(较上一季度减少1.47%)","perCapita":"24425股","listingDate":"2001-06-08","address":"广东省深圳市南山区高新区北区朗山路17号健康元药业集团大厦","registeredCapital":"182945万元","survey":" 健康元药业集团股份有限公司的主营业务是医药产品及保健品研发、生产及销售。公司的主要产品是化学制剂、生物制品、化学原料药及中间体、中药制剂、诊断试剂及设备、保健食品。","listedPrice":24.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"健康元(600380)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供健康元(600380)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"健康元,600380,健康元股票,健康元股票老虎,健康元股票老虎国际,健康元行情,健康元股票行情,健康元股价,健康元股市,健康元股票价格,健康元股票交易,健康元股票购买,健康元股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"健康元(600380)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供健康元(600380)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}